首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences.
【24h】

Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences.

机译:在欧洲长期使用阿片类药物药物治疗慢性非癌性疼痛的原因和后果。

获取原文
获取原文并翻译 | 示例
       

摘要

According to the 2005 Pain in Europe Survey, the use of opioids to treat patients with chronic noncancer pain varies considerably among different countries in Europe. Undertreatment of chronic pain is common. This review examines the possible causes and consequences of limiting opioid availability to these patients. The causes of inadequate opioid use include medical, ethical, and cultural factors that influence prescribing decisions; legislative and health care system controls that serve to restrict the use of opioids for long-term treatment of non-cancer-related pain conditions; and poor treatment acceptance by patients. The validity of these restrictions is discussed in relation to the need to protect patients and society from harm due to adverse events, and the potential for misuse and abuse with prescribed opioids. This is balanced against the therapeutic goal of providing the best available pain-relieving treatment and to avoid the consequences of unnecessary suffering in patients with chronic noncancer pain.
机译:根据2005年欧洲疼痛调查,在欧洲不同国家/地区使用阿片类药物治疗慢性非癌性疼痛的患者差异很大。慢性疼痛的治疗不足是常见的。这篇综述探讨了限制这些患者使用阿片类药物的可能原因和后果。阿片类药物使用不足的原因包括会影响处方决定的医学,伦理和文化因素;立法和卫生保健系统控制措施,旨在限制使用阿片类药物长期治疗非癌症相关性疼痛状况;并且患者对治疗的接受度很差。这些限制的有效性与保护患者和社会免受不良事件造成的伤害的需要以及处方阿片类药物的滥用和滥用的可能性有关。这与提供最佳可用的缓解疼痛的治疗目标以及避免在慢性非癌性疼痛患者中避免不必要的痛苦的治疗目标相平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号